ポスター：バイオ医薬品の緻密な特性解析と品質モニタリングのためのエンタープライズソフトウェアソリューション

Genedata Biopharma Partner Symposium, Basel, Switzerland
March 6, 2024

Mass spectrometry (MS) has become a key analytical technology throughout the entire biopharmaceutical lifecycle, from in-depth characterization of biotherapeutic candidates during discovery and development, to quality monitoring of drug products during manufacturing. By providing a single, scalable solution for all MS data analysis, processing, and reporting while seamlessly integrating into existing analytical processes, the Genedata Expressionist^® enterprise software platform accelerates and streamlines biotherapeutic development across entire organizations.